Northbank Communications
Northbank Helps Clients Achieve Success

We thought you might like to know that over the last year alone, Northbank has successfully delivered communications programmes that have helped our life sciences clients raise over €275 million in private equity financings, over €550 million in partnering deals and facilitated two major acquisitions by blue chip pharma companies.
Venture Financing
Ablynx AMT Cerenis Therapeutics
€40m
Series C Financing
€22m
Series A Financing
€42m
Series B Financing
Corp & Fin Comms
Worldwide
Corp & Fin Comms
Worldwide
Media Relations
Across Europe
ESBATech MTM Nitec Pharma
€30m
Series B Financing
€22m
Series C Financing
€20m
Series B Financing
Media Relations
Across Europe
Corp & Fin Comms
Worldwide
Corp Comms
Worldwide
Affimed Therapeutics AG Pronota Santaris Pharma
€25m
Series B Financing
€15m
Series A Financing
£20m
Series B Financing
Corp & Fin Comms
Worldwide
Corp, Fin & Commercial PR
Worldwide
Corp & Fin Comms
Worldwide
Deals
Ablynx Ablynx Biacore
$265m Deal with
Boehringer Ingelheim
$213m Deal
with Wyeth
Acquisition by
GE Healthcare
Corp & Fin Comms
Worldwide
Corp & Fin Comms
Worldwide
Marketing Comms
Worldwide
BioInvent Forbion Capital Partners Oxford BioMedica
$190m Deal
with Genentech
Spin-out from
ABN AMRO CLS
$690m Deal with
Sanofi-Aventis
Corp Comms
Worldwide
Media Relations
Worldwide
Corp Image & Commercial PR
Worldwide
PowderMed Sigma - Oxford Biomedica Solexa
Acquisition by
Pfizer
Joint License Deal
with GSK
Acquisition by
Illumina
Corp, Fin & Healthcare Comms Prior to Pfizer Acquisition
Marketing Comms
Worldwide
Marketing Comms
Worldwide
If you would like further information on how Northbank can help you, or your portfolio companies, achieve similar success please contact:

Katja Stout:
Tel: +44 (0)207 268 3244
Email: k.stout@northbankcommunications.com

Sue Charles:
Tel: +44 (0)207 268 3248
Email: s.charles@northbankcommunications.com
Web: www.northbankcommunications.com
30th April 2007 Science | Leadership | Passion | Communication